Literature DB >> 16417692

Neonatal screening of glucose-6-phosphate dehydrogenase deficiency in Yanbu, Saudi Arabia.

Mohammed Ahmed Muzaffer1.   

Abstract

OBJECTIVE: To determine the prevalence of glucose-6-phosphate dehydrogenase (G6PD) deficiency in the population tested, and to evaluate the prevalence of neonatal jaundice in newborns with G6PD deficiency.
METHODS: Cord blood of all babies born between October 1996 and October 1998 at the Royal Commission Medical Center in Yanbu, Saudi Arabia, was screened for G6PD deficiency by fluorescent spot test. The results of screening of cord blood samples were reported to the physician in charge, and also placed on the files of the babies and their mothers. These babies were observed for 72 h and discharged if no jaundice developed.
RESULTS: During this two-year period, 2,505 neonatal cord blood samples from 1,278 boys and 1,227 girls were screened for G6PD. There were 50 positive results for G6PD deficiency (39 boys and 11 girls), and the prevalence was estimated to be around 2%. The sex-specific prevalence for boys was 3.05%, and for girls 0.9%. Male to female ratio was 3:1. Neonatal jaundice developed in six (12%) babies, five male and one female. All were treated with phototherapy and discharged within one week of birth.
CONCLUSION: The prevalence of G6PD is relatively high in Yanbu. Routine neonatal screening in areas with a high prevalence of G6PD in Saudi Arabia is justifiable.

Entities:  

Mesh:

Year:  2005        PMID: 16417692     DOI: 10.1258/096914105775220660

Source DB:  PubMed          Journal:  J Med Screen        ISSN: 0969-1413            Impact factor:   2.136


  9 in total

1.  Thrombophilic gene polymorphism studies in G6PD deficient individuals from Saudi population.

Authors:  Khalid K Alharbi; Imran Ali Khan; Rabbani Syed
Journal:  Bioinformation       Date:  2012-12-19

Review 2.  Individualized medicine enabled by genomics in Saudi Arabia.

Authors:  Muhammad Abu-Elmagd; Mourad Assidi; Hans-Juergen Schulten; Ashraf Dallol; Peter Pushparaj; Farid Ahmed; Stephen W Scherer; Mohammed Al-Qahtani
Journal:  BMC Med Genomics       Date:  2015-01-15       Impact factor: 3.063

3.  Evaluation of neonatal jaundice in the Makkah region.

Authors:  Abdulaziz Alkhotani; Essam Eldin Mohamed Nour Eldin; Amal Zaghloul; Shakil Mujahid
Journal:  Sci Rep       Date:  2014-04-25       Impact factor: 4.379

4.  Genetic Epidemiology of Glucose-6-Phosphate Dehydrogenase Deficiency in the Arab World.

Authors:  C George Priya Doss; Dima R Alasmar; Reem I Bux; P Sneha; Fadheela Dad Bakhsh; Iman Al-Azwani; Rajaa El Bekay; Hatem Zayed
Journal:  Sci Rep       Date:  2016-11-17       Impact factor: 4.379

5.  Screening for glucose-6-phosphate dehydrogenase deficiency in neonates: a comparison between cord and peripheral blood samples.

Authors:  Saif AlSaif; Ma Bella Ponferrada; Khalid AlKhairy; Khalil AlTawil; Adel Sallam; Ibrahim Ahmed; Mohammed Khawaji; Khalid AlHathlol; Beverly Baylon; Ahmed AlSuhaibani; Mohammed AlBalwi
Journal:  BMC Pediatr       Date:  2017-07-11       Impact factor: 2.125

6.  Prevalence of Glucose-6-Phosphate Dehydrogenase Deficiency Among Children in Eastern Saudi Arabia.

Authors:  Muneer H Albagshi; Suad Alomran; Somaya Sloma; Murtadha Albagshi; Abdullah Alsuweel; Helal AlKhalaf
Journal:  Cureus       Date:  2020-10-29

Review 7.  Insights into National Laboratory Newborn Screening and Future Prospects.

Authors:  Ahmed H Mujamammi
Journal:  Medicina (Kaunas)       Date:  2022-02-11       Impact factor: 2.948

8.  Prevalence of selected congenital anomalies in Saudi children: a community-based study.

Authors:  Abdullah AlSalloum; Mohammad Issa El Mouzan; Abdullah AlHerbish; Ahmad AlOmer; Mansour Qurashi
Journal:  Ann Saudi Med       Date:  2015 Mar-Apr       Impact factor: 1.526

9.  Consanguinity and major genetic disorders in Saudi children: a community-based cross-sectional study.

Authors:  Mohammad I El Mouzan; Abdullah A Al Salloum; Abdullah S Al Herbish; Mansour M Qurachi; Ahmad A Al Omar
Journal:  Ann Saudi Med       Date:  2008 May-Jun       Impact factor: 1.526

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.